Literature DB >> 19407728

Selective benefit of donepezil on oral naming in Alzheimer's disease in men compared to women.

Meghan L Davis, Anna M Barrett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407728      PMCID: PMC2928142          DOI: 10.1017/s1092852900020174

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  8 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Can drug therapies improve language functions of individuals with aphasia? A review of the evidence.

Authors:  Reva B Klein; Martin L Albert
Journal:  Semin Speech Lang       Date:  2004-05       Impact factor: 1.761

Review 3.  A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.

Authors:  A Takeda; E Loveman; A Clegg; J Kirby; J Picot; E Payne; C Green
Journal:  Int J Geriatr Psychiatry       Date:  2006-01       Impact factor: 3.485

4.  Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects.

Authors:  Anna M Barrett; Paul J Eslinger; Noel H Ballentine; Kenneth M Heilman
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

5.  Mild traumatic brain injury: effects on naming in word retrieval and discourse.

Authors:  Kristin A King; Monica S Hough; Marianna M Walker; Michael Rastatter; Don Holbert
Journal:  Brain Inj       Date:  2006-06       Impact factor: 2.311

Review 6.  Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.

Authors:  Wendy M Haywood; Elizabeta B Mukaetova-Ladinska
Journal:  Am J Geriatr Pharmacother       Date:  2006-09

7.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

8.  Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.

Authors:  S H MacGowan; G K Wilcock; M Scott
Journal:  Int J Geriatr Psychiatry       Date:  1998-09       Impact factor: 3.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.